Immune checkpoint inhibitors promising role in cancer therapy: clinical evidence and immune-related adverse events
Seyed Mohammadmahdi Meybodi, Bahareh Farasati Far, Ali Pourmolaei, Farid Baradarbarjastehbaf, Maryam Safaei, Niloufar Mohammadkhani, Ali Akbar Samadani
Topics & Concepts
IpilimumabPembrolizumabNivolumabMedicineAvelumabCancerImmune checkpointAdverse effectImmune systemTremelimumabImmunologyOncologyInternal medicineImmunotherapyCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchLung Cancer Treatments and Mutations